SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-068364
Filing Date
2023-12-05
Accepted
2023-12-05 18:53:09
Documents
1
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6358
  Complete submission text file 0000950170-23-068364.txt   7666
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043
Business Address
Mokari Atabak (Reporting) CIK: 0001678419 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 231468052